戻る Agendas
Session 0703 Development of Biosimilars in China: Interpretation of Biosimilar Guidance, Opportunities and Challenges - I
Session Chair(s)
Joe Zhang
Co-founder and CEO
BJ Bioscience Inc., China
Speaker(s)
EMA & Biosimilar update Trends and developments in marketing authorisation applications, scientific advice procedures and policies
Evangelos Kotzagiorgis, MPHARM, MS
EMA, Netherlands
Pharmaceutical Quality Senior Specialist, Pharmaceutical Quality Office, Human M
Global mAb Biosimilar Industry Challenges and Opportunities from Policy to Reality
Joe Zhou
Genor BioPharm, Walvax Bio Group, China
CEO